Step Down FSH Approach and Late Follicular Phase in Progesterone Level — FSH  

Progesterone Resistance Clinical Trial

Official title: Impact of Step-down Approach During Late Follicular Phase in Recombinant FSH-stimulation Dosage for IVF on Progesterone Level on the Day of Final Oocyte Maturation

Status Completed

Clinical Trial Summary

Step-down approach and late follicular phase progesterone level

Clinical Trial Description

The study will be performed using the stimulation medication Gonal-F which is a recombinant FSH-preparation. Due to application as pen-device, it allows reduction of the stimulation dosage in steps of 12.5IU.

It is important to evaluate the dynamics of progesterone-rise after final oocyte maturation, as this dynamic might also have an influence on the receptivity of the endometrium. ;

Related Conditions & MeSH terms

• Progesterone Resistance

• NCT number: NCT03356964
• Study type: Interventional
• Source: IVI Middle East Fertility Clinic
• Status: Completed
• Phase: Early Phase 1
• Start date: November 23, 2017
• Completion date: August 31, 2020